Search Results - "Xiong, Baizhu"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma by Hou, Changlong, Xiong, Baizhu, Zhou, Lei, Fei, Yipeng, Shi, Changgao, Zhu, Xianhai, Xie, Tao, Wu, Yulin

    Published in BMC cancer (27-03-2024)
    “…The safety and efficacy of transarterial chemoembolization plus molecular targeted therapy (MTT) combined with immune checkpoint inhibitors (ICIs) in primary…”
    Get full text
    Journal Article
  2. 2

    Dual-Energy Computed Tomography Parameters Combined With Inflammatory Indicators Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer by Wei, Longyu, Wu, Yaoyuan, Bo, Juan, Fu, Baoyue, Sun, Mingjie, Zhang, Yu, Xiong, Baizhu, Dong, Jiangning

    Published in Cancer control (01-06-2024)
    “…Cervical lymph node metastasis (CLNM) is considered a marker of papillar Fethicy thyroid cancer (PTC) progression and has a potential impact on the prognosis…”
    Get full text
    Journal Article
  3. 3

    Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors by Xiong, Baizhu, Fu, Baoyue, Wu, Yulin, Gao, Fei, Hou, Changlong

    “…Purpose Immune checkpoint inhibitors (ICIs) with anti-PD-1/PD-L1 antibody are promising treatments for hepatocellular carcinoma (HCC), but lack reliable…”
    Get full text
    Journal Article